Cambridge, United States
River Stone Biotech Inc. is a biotechnology startup based in Cambridge, MA, US with development sites in Denmark and Australia and an operational hub in the UK. The company specializes in synthesizing biology to create and produce chemistry, focusing on small molecules and ADMET. They have a highly experienced management team that has successfully taken multiple projects from concept to commercial-scale production. River Stone Biotech is committed to delivering life-changing APIs and formulations through innovative production methods that blend synthetic biology and chemistry processes.
In 2018, River Stone Biotech was founded and has since been dedicated to making a meaningful contribution to the global Opioid Dependence/Substance Abuse Prevention programs. The company works collaboratively with a select group of global providers, establishing a virtual cross-functional operation to enable its API offering.
While there is no publicly disclosed information about the company's last investment and the associated investors, River Stone Biotech Inc. showcases promising potential within the biotechnology sector. With its innovative approach and focus on addressing critical health issues, it has the potential to attract significant interest from venture capital firms and investors seeking impactful opportunities in the biotech industry.
